About: The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 07 August 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в серпні 2008 (uk) scientific article published on 07 August 2008 (en) مقالة علمية نشرت في 07 أغسطس 2008 (ar)
publication date	wds:Q37240451-BA4F6B60-020A-4796-8BBD-21AA4A23E2F2
publication date	2008-08-07 00:00:00Z (xsd:dateTime)
author name string	wds:Q37240451-4F14FD3D-F10E-4377-B427-110709EEF1F1 wds:Q37240451-A68FD90D-D9F8-498E-AD46-A430EF5A8DC4 wds:Q37240451-B51BDA6B-A3D7-4D47-9F13-C0DDEAD829AE wds:Q37240451-DE71810B-11D2-478A-AC77-D49638E80960
author name string	Jean Bourhis Nicolas Magné Pierre Castadot Mithra Ghalibafian
rdfs:label	The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials (en) The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials (nl) The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials (ast)
skos:prefLabel	The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials (en) The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials (nl) The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials (ast)
name	The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials (en) The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials (nl) The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials (ast)
author	wds:Q37240451-0E2912A3-B549-4F0D-B007-F73982314EEF wds:Q37240451-1174A851-2FDE-4D71-A6D7-86F4658D3FE5 wds:Q37240451-E4C89A94-99E9-4547-B263-017155774B8E wds:Q37240451-E747604B-8CB3-4BDF-A1DD-F2A3B7819E46
author	Cyrus Chargari Jean-Charles Soria Christine Haie-Meder Eric Deutsch
title	wds:Q37240451-FE2712FF-D8BC-4358-A737-C0B4FBDC6DBE
title	The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials (en)
page(s)	wds:Q37240451-79502080-4893-4189-BD7F-6B039BF3FFB7
page(s)	2133-2143
instance of	wds:Q37240451-02DE0D7B-B81E-4D09-BC9E-C99480C88CAC wds:Q37240451-16154afb-0e83-4a79-b574-9cc57da183da
instance of	review article scholarly article
main subject	wds:Q37240451-9FDEC243-17D3-447E-ADD3-4A3A78B006E3
main subject	radiation therapy
PubMed ID	wds:Q37240451-7A4A344E-79C5-4201-9303-676138B495D2
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18692389
PubMed ID	18692389
published in	wds:Q37240451-52AF7744-2086-49DE-B6D0-7BA965220CAF
published in	European Journal of Cancer
issue	wds:Q37240451-3D2C5746-CF70-496D-8BD9-526FF6C65DC4
volume	wds:Q37240451-866B5402-4AE1-4728-B721-24F4323C4E0E
issue	15
volume	44
DOI	wds:Q37240451-8BCCB083-9FFB-4CF3-AD34-E219B9525811
DOI	http://dx.doi.org/10.1016/J.EJCA.2008.06.029
DOI	10.1016/J.EJCA.2008.06.029
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37240451
is cites work of	Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK Whole-brain radiation therapy in breast cancer patients with brain metastases Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches Molecular targets for tumor radiosensitization Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments Lapatinib-capecitabine versus capecitabine alone as radiosensitizers in RAS wild-type resectable rectal cancer, an adaptive randomized phase II trial (LaRRC trial): study protocol for a randomized controlled trial Clinical study on gefitinib combined with γ-ray stereotactic body radiation therapy as the first-line treatment regimen for senile patients with adenocarcinoma of the lung (final results of JLY20080085).
is cites work of	wds:Q33562476-18062A1B-9505-4464-86A3-80A6C3C97F25 wds:Q37272825-6EE30DEF-CDDB-4065-857E-C450887F785D wds:Q37489947-47E31BBD-EAE3-41F3-BCDD-17494736E2FA wds:Q36126009-2F53F476-13C6-4BF7-8ACB-6C609B8C1819 wds:Q38155932-05724893-D235-456F-B679-B6C382EF5C63 wds:Q37772075-C51E53AB-0DBF-4452-A661-5602E171A8D2 wds:Q37560695-FB91B332-C53F-416F-9A5D-3A985EA797C8

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software